.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Accenture
Moodys
Daiichi Sankyo
Boehringer Ingelheim
McKesson
Fish and Richardson
Baxter
Chinese Patent Office
McKinsey

Generated: September 23, 2017

DrugPatentWatch Database Preview

Smithkline Beecham Company Profile

« Back to Dashboard

What is the competitive landscape for SMITHKLINE BEECHAM, and when can generic versions of SMITHKLINE BEECHAM drugs launch?

SMITHKLINE BEECHAM has six approved drugs.

There are two US patents protecting SMITHKLINE BEECHAM drugs.

Summary for Applicant: Smithkline Beecham

Patents:2
Tradenames:6
Ingredients:6
NDAs:6
Drug Master File Entries: (click here to view)2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Smithkline Beecham
AXID
nizatidine
CAPSULE;ORAL019508-002Apr 12, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-003Sep 14, 1995ABRXYesNo► Subscribe► Subscribe► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-002Oct 20, 2006RXYesNo► Subscribe► SubscribeY► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-002Oct 20, 2006RXYesNo► Subscribe► SubscribeY► Subscribe
Smithkline Beecham
RELAFEN
nabumetone
TABLET;ORAL019583-001Dec 24, 1991DISCNYesNo► Subscribe► Subscribe► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-003Oct 20, 2006RXYesYes► Subscribe► SubscribeY► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-001Sep 14, 1995ABRXYesNo► Subscribe► Subscribe► Subscribe
Smithkline Beecham
DYNACIRC
isradipine
CAPSULE;ORAL019546-001Dec 20, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Smithkline Beecham
AXID
nizatidine
CAPSULE;ORAL019508-001Apr 12, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-004Oct 20, 2006RXYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Smithkline Beecham

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-001Oct 20, 2006► Subscribe► Subscribe
Smithkline Beecham
LOVAZA
omega-3-acid ethyl esters
CAPSULE;ORAL021654-001Nov 10, 2004► Subscribe► Subscribe
Smithkline Beecham
RELAFEN
nabumetone
TABLET;ORAL019583-001Dec 24, 1991► Subscribe► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-002Oct 20, 2006► Subscribe► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-004May 29, 1997► Subscribe► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-004Oct 20, 2006► Subscribe► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-003Oct 20, 2006► Subscribe► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-003Sep 14, 1995► Subscribe► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-003Oct 20, 2006► Subscribe► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-004May 29, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for SMITHKLINE BEECHAM drugs

Drugname Dosage Strength Tradename Submissiondate
omega-3-acid ethyl esters
Capsules1 g
LOVAZA
11/10/2008
nizatidine
Oral Solution15 mg/mL
AXID
5/14/2008
carvedilol phosphate
Extended-release Capsules10 mg and 20 mg
COREG CR
3/18/2008
carvedilol phosphate
Extended-release Capsules40 mg
COREG CR
12/21/2007
carvedilol phosphate
Extended-release Capsules80 mg
COREG CR
11/19/2007

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
UBS
Fuji
Baxter
Novartis
Chinese Patent Office
Cerilliant
Johnson and Johnson
Argus Health
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot